These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21697774)

  • 1. Therapeutic efficacy of polyclonal tregs does not require rapamycin in a low-dose irradiation bone marrow transplantation model.
    Pilat N; Klaus C; Gattringer M; Jaeckel E; Wrba F; Golshayan D; Baranyi U; Wekerle T
    Transplantation; 2011 Aug; 92(3):280-8. PubMed ID: 21697774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin.
    Steiner D; Brunicki N; Bachar-Lustig E; Taylor PA; Blazar BR; Reisner Y
    Exp Hematol; 2006 Jun; 34(6):802-8. PubMed ID: 16728286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance induction through megadose bone marrow transplantation with two-signal blockade.
    Lee EN; Lee J; Kim EY; Park HJ; Chang CY; Jung DY; Choi SY; Lee SK; Kwon CH; Joh JW; Kim SJ
    J Surg Res; 2006 Jan; 130(1):102-9. PubMed ID: 16183077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers.
    Colson YL; Wren SM; Schuchert MJ; Patrene KD; Johnson PC; Boggs SS; Ildstad ST
    J Immunol; 1995 Nov; 155(9):4179-88. PubMed ID: 7594573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of cyclophosphamide to T-cell depletion-based nonmyeloablative conditioning allows donor T-cell engraftment and clonal deletion of alloreactive host T-cells after bone marrow transplantation.
    Xu H; Chilton PM; Huang Y; Schanie CL; Yan J; Ildstad ST
    Transplantation; 2007 Apr; 83(7):954-63. PubMed ID: 17460568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of the CD40/CD154 pathway enhances T-cell-depleted allogeneic bone marrow engraftment under nonmyeloablative and irradiation-free conditioning therapy.
    Pan Y; Luo B; Sozen H; Kalscheuer H; Blazar BR; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2003 Jul; 76(1):216-24. PubMed ID: 12865813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion of Lin- bone marrow cells results in multilineage macrochimerism and skin allograft tolerance in minimally conditioned recipient mice.
    Anam K; Amare MF; Zins SR; Davis TA
    Transpl Immunol; 2010 Oct; 24(1):69-75. PubMed ID: 20950686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A partial conditioning strategy for achieving mixed chimerism in the rat: tacrolimus and anti-lymphocyte serum substantially reduce the minimum radiation dose for engraftment.
    Gammie JS; Li S; Colson YL; Demetris AJ; Neipp M; Ildstad ST; Pham SM
    Exp Hematol; 1998 Sep; 26(10):927-35. PubMed ID: 9728927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloresistance to K locus class I-mismatched bone marrow engraftment is mediated entirely by CD4+ and CD8+ T cells.
    Hayashi H; LeGuern C; Sachs DH; Sykes M
    Bone Marrow Transplant; 1996 Aug; 18(2):285-92. PubMed ID: 8864436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance.
    Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H
    Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function.
    Su Y; Huang X; Wang S; Min WP; Yin Z; Jevnikar AM; Zhang ZX
    Eur J Immunol; 2012 May; 42(5):1216-25. PubMed ID: 22539294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
    Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
    Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-regulatory cell treatment prevents chronic rejection of heart allografts in a murine mixed chimerism model.
    Pilat N; Farkas AM; Mahr B; Schwarz C; Unger L; Hock K; Oberhuber R; Aumayr K; Wrba F; Wekerle T
    J Heart Lung Transplant; 2014 Apr; 33(4):429-37. PubMed ID: 24468120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
    Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S
    Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.